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Innate immunitysvirus Papiine herpesvirus 2 (HVP2) exhibit one of two distinct phenotypes in
mice: extremely neurovirulent or apathogenic. Previous studies implicated the type I interferon (IFN)
response as being a major factor in controlling infection by apathogenic isolates. To further investigate the
possibility that the host IFN-β response underlies the pathogenicity of the two HVP2 subtypes, the
susceptibility of mice lacking the IFN-β receptor (IFNAR−/−) to infection was examined. Apathogenic
isolates of HVP2 (HVP2ap) replicated in IFNAR− /− primary mouse dermal ﬁbroblast (PMDF) cultures as well
as neurovirulent (HVP2nv) isolates. IFNAR− /− mice were also susceptible to lethal infection by HVP2ap
isolates. Unlike Balb/c or parental 129 mice, LD50 and ID50 values for HVP2ap were the same in IFNAR
− /−
mice indicating that in these mice infection always progressed to death. HVP2ap replicated in the skin at the
site of inoculation and invaded dorsal root ganglia as efﬁciently as HVP2nv in IFNAR− /− mice. Since the
virion host shutoff (vhs) protein encoded by the UL41 gene of herpes simplex virus has been implicated in
circumventing the host IFN-β response and the phenotype of UL41 deletion mutants of HSV is very similar to
that of HVP2ap isolates, the UL41 gene was deleted from HVP2nv (Δ41) and replaced with the UL41 ORF
from HVP2ap (Δ41C). Like the parental HVP2nv virus, the Δ41C recombinant replicated efﬁciently in Balb/c
PMDFs and did not induce a strong IFN-β response. The neuropathogenicity of the Δ41C recombinant was
also the same as the parental HVP2nv virus in Balb/c mice, indicating that the vhs protein does not underlie
the different neuropathogenic phenotype of HVP2ap and HVP2nv. In contrast, the Δ41 deletion virus induced
a strong IFN-β response but was still able to undergo multiple rounds of replication in PMDF cultures, albeit
at a slower pace than the parental HVP2nv. This was reﬂected in vivo as the Δ41 mutant had an LD50
equivalent to that of the parental HVP2nv virus although the time to death was longer. These results indicate
that while the vhs protein is involved in preventing and/or suppressing an IFN-β response, it is not
responsible for the ability of HVP2nv to overcome IFN-β induced resistance of uninfected cells and does not
underlie the divergent pathogenicity of the two HVP2 subtypes in mice.
© 2009 Elsevier Inc. All rights reserved.Introduction
The baboon herpesvirus Papiine herpesvirus 2 (Herpesvirus papio 2;
HVP2) is very closely related to both herpes simplex virus (HSV) of
humans and Macacine herpesvirus 1 (monkey B virus; BV) of
macaques (Eberle and Hilliard, 1995; Huff and Barry, 2003; Keeble,
1960; Palmer, 1987; Weigler, 1992; Whitely and Hilliard, 2001). While
BV causes a severe and usually fatal encephalomyelitis when
transmitted to humans or other non-macaque primates (Huff andsity of North Carolina, Chapel
ll rights reserved.Barry, 2003; Loomis et al., 1981; Sabin andWright, 1934; Thompson et
al., 2000), there are no reported incidents of HVP2 infection or death
in humans. However, in Balb/c mice one subtype of HVP2 (HVP2ap)
does not produce clinical signs of disease and infection results in only
minimal tissue destruction at both the site of inoculation and within
both the peripheral and central nervous system (PNS and CNS). In
contrast, the second subtype (HVP2nv) produces a fulminant, rapidly
fatal CNS infection (Ritchey et al., 2002; Rogers et al., 2003, 2006).
HVP2 has however caused fatal infections in young baboons (Wolf et
al., 2006) and an HVP2nv isolate was also recently reported to be the
cause of a fatal neurological infection in a Colobus monkey (Troan et
al., 2007). The clinicopathogenesis of HVP2nv in mice closely parallels
what has been observed in human BV infections and provides an
excellent model system for examining host-virus interactions within
the context of cross-species infections (Rogers et al., 2006).
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interactions between virus and host that determines the pathogenesis
and clinical outcome of infection (Brandt, 2005; Enquist et al., 1998;
Mossman and Ashkar, 2005; Rouse and Lopez, 1984). Thus, virtually
any viral factor which affects the ability of a virus to replicate and/or
spread within a host can be considered a virulence factor. In addition,
both viral dose and route of inoculation can inﬂuence the ability of a
virus to establish a productive infectionwithin a given host (Breshears
et al., 2005; Weeks et al., 2000). In HSV infection of mice, the
efﬁciency of viral replication at the peripheral site of infection is
directly related to the ability of the virus to enter sensory neurons and
invade the CNS (Yamada et al., 1986). However, once a virus has
gained entry to a host organism, themost important host determinant
of pathogenicity is likely the host innate immune response (Mossman
and Ashkar, 2005; Simons and Nash, 1984).
A critical component of the innate anti-viral response is production
of the type I interferons α and β (IFN-α, IFN-β). IFN-α is rapidly
produced by infected plasmacytoid dendritic cells (pDCs) or when
they are stimulated by recognition of viral components via toll-like
receptors (TLRs) either through endocytosis of viral particles or
autophagy of infected cells (Lee et al., 2007). The ability of pDCs to
mount an early IFN-α response is due to constitutive expression of the
interferon regulatory factor (IRF)-7 while in other cell types, baseline
IRF7 expression is weak and only moderately induced by viral
infection (Dai et al., 2004; Lee et al., 2007).
IFN-β is rapidly induced in many cell types (including those
infected by herpesviruses such as ﬁbroblasts and epithelial cells) due
to their constitutive expression of IRF-3. IFN-α and -β produced by
infected cells binds to the IFN-α/β receptor (IFNAR) initiating a signal
transduction cascade via the Janus associated kinase — signal
transducer and activator of transcription (Jak-Stat) pathway (Darnell
et al., 1994; Goodbourn et al., 2000). The end result of this pathway isFig. 1. Plaque formation by HVP2 subtypes in BALB/c, 129 and IFNAR− /− PMDF cultures. Con
at 48 h PI. HVP2nv isolates produced complete CPE within 48 h in all three cell types. HVP2
failed to enlarge with time. In contrast, HVP2ap isolates completely destroyed IFNAR− /− cuthat infected cells are recognized and destroyed while uninfected cells
are protected from viral infection, thereby limiting the ability of the
viral infection to spread. Although infected IFNAR−/− cells are
capable of expressing IFN, the lack of the receptor for IFN-α/β
prevents the signal transduction cascade via the Jak/Stat pathway,
resulting in no ampliﬁcation of the IFN-β response, and so neighbor-
ing uninfected cells remain sensitive to viral infection.
The pathogenic phenotype of HVP2ap in mice is similar to that
described for HSV: normal replication in vitro but reduced neuro-
pathogenicity in vivo (Rogers et al., 2003). HVP2ap-infected primary
mouse dermal ﬁbroblast (PMDF) cultures have also been shown to
produce more IFN-β than HVP2nv-infected PMDF cultures (Rogers et
al., 2007). Further, pretreatment of Balb/c PMDF cell cultures with
exogenous murine IFN-β signiﬁcantly decreased titers of HVP2ap but
not HVP2nv, suggesting that HVP2nv is not effectively controlled by
the mouse IFN-β response. Similar phenotypes have been observed
with other alpha-herpesviruses and experimental animalmodels have
proven invaluable in dissecting the mechanisms of numerous viral
anti-IFN genes.
The virion host shutoff (vhs) protein of HSV1 and HSV2 encoded by
the UL41 gene is probably the best known example of a herpesvirus
protein responsible for abrogating the type I IFN response in infected
cells (Duerst and Morrison, 2004; Korom et al., 2008; Suzutani et al.,
2000). The vhs protein is a component of the virion tegument, and so
is released into the cytoplasm of cells immediately on infection. The
HSV vhs has RNase activity and functions to degrade certain mRNAs in
infected cells (Esclatine et al., 2004; Everly et al., 2002; Karr and Read,
1999). Late in infection the vhs protein interacts with the viral α-
transducing factor VP16. This interaction reduces the RNase activity of
vhs, allowing accumulation of viral transcripts (Lam et al., 1996;
Schmelter et al., 1996; Strand and Leib, 2004). Deletion of the UL41
gene results in higher levels of IFN-β production in infected cellﬂuent PMDF monolayers were inoculated at an MOI of 0.25 PFU/cell and photographed
ap isolates produced discrete plaques by 24 h in Balb/c and 129 cell cultures, but these
ltures by 48 h PI.
Fig. 3. IFN-β production in HVP2ap and HVP2nv infected PMDF cultures. PMDF cultures
derived from three mouse strains were infected with HVP2nv strains OU1-76 (black)
and X313 (hatched) or HVP2ap strains OU2-5 (light gray) and A951 (dark gray) at an
MOI of 1.0 PFU/cell. Media was collected at 24 h PI and IFN-β quantitated by ELISA. In
Balb/c and 129 cells, the IFN-β concentration was signiﬁcantly higher in HVP2ap
infected than in HVP2nv infected cultures (as indicated by asterisks above the standard
error bars); therewas no signiﬁcant difference in IFN-β produced in IFNAR− /− cultures
infected with the two HVP2 subtypes.
282 K.M. Rogers et al. / Virology 386 (2009) 280–289cultures and dramatically affects the pathogenicity of HSV in mice
(Korom et al., 2008; Smith et al., 2000, 2001; Strand and Leib, 2004;
Strelow and Leib, 1995, 1996). Recently, it has been shown that
selective mutation of the RNase activity of the HSV2 vhs affects
pathogenicity of the virus (Korom, et al., 2008).
The availability of IFNAR−/− knockout mice which do not express
the IFN-α/β receptor (Muller et al., 1994) provides an ideal model
system for investigating the role for IFN-β in HVP2 cross-species
infections. These studies were undertaken to assess the role of IFN-β
and the HVP2 vhs in vivo.
Results
Previous experiments with Balb/c PMDF cultures suggested that
IFN-βmay differentially affect replication of the two HVP2 subtypes in
vitro and that HVP2nv may be more efﬁcient than HVP2ap at
preventing and/or overcoming the expression of IFN-β (Rogers et
al., 2007). To further test the role of the IFN-β response in controlling
HVP2 infection in the mouse model, PMDF cultures were prepared
from parental 129 and IFNAR− /− knockout mice and the ability of
HVP2ap and HVP2nv to replicate in them was assessed.
Replication of both subtypes of HVP2 was compared in PMDF
cultures prepared from Balb/c, 129 and IFNAR−/− mice. Cultures
were infected with two isolates each of HVP2ap or HVP2nv at an MOI
of 0.25 PFU/cell and observed for plaque formation over 3 days. As
shown in Fig. 1, HVP2nv strains replicated equally well in PMDFs
derived from all three mouse strains. Large plaques were evident by
24 h PI and the cultures were completely destroyed by 48 h PI. As
described previously for Balb/c PMDFs (Rogers et al, 2007), HVP2ap
strains formed plaques in Balb/c and 129 cultures that were
equivalent in size to those of HVP2nv strains at 24 h PI. However,
HVP2ap plaques ceased to enlarge much after 24 h and by 72 h PI
uninfected cells had ﬁlled in the site of the initial plaques. In contrast,
HVP2ap strains replicated in IFNAR−/− PMDF cultures as efﬁciently as
HVP2nv strains; plaques were evident at 24 h PI, and by 48 h PI the
monolayers were completely involved.
To quantitate replication of the two HVP2 subtypes in PMDFs, cell
cultures derived from the three mouse strains were infected as above
and infectious virus quantitated by plaque assay at 48 h PI (Fig. 2).
Consistent with the observed formation of plaques, HVP2nv strains
produced signiﬁcantly more infectious virus than HVP2ap strains in
both Balb/c and 129 PMDF cultures (pN0.05). Although levels of
infectious virus in HVP2ap infected IFNAR− /− cultures wereFig. 2. Replication of HVP2 subtypes in Balb/c, 129 and IFNAR− /− PMDF cultures.
Conﬂuent Balb/c (light gray), 129 (dark gray) or IFNAR− /− (black) PMDF cultures were
inoculated with HVP2ap isolates A951 and OU2-5 or HVP2nv isolates X313 and OU1-76
at an MOI of 0.25 PFU/cell. At 48 h PI, infected cells were scraped into the media and
infectious virus quantitated. There was no signiﬁcant difference in the amount of
HVP2nv produced in the three cell lines while HVP2ap isolates produced signiﬁcantly
more infectious progeny virus in IFNAR− /− cells than in either Balb/c or 129 cells (as
indicated by asterisks above the standard error bars).approximately 10-fold less than in HVP2nv infected IFNAR− /−
cultures, HVP2ap strains produced signiﬁcantly more infectious virus
in IFNAR− /− PMDF cultures than in Balb/c or 129 cultures (pN0.05).
We previously demonstrated that HVP2ap infected PMDF cultures
derived from Balb/c mice produced higher levels of IFN-β than did
HVP2nv infected cultures (Rogers et al., 2007). Since IFNAR−/− mice
lack the IFN-β receptor, uninfected cells in IFNAR− /− PMDF cultures
should not be able to respond to the production of IFN-β by infected
cells. PMDF cultures prepared from the three mouse strains were
infected at anMOI=1 PFU/cell andmedia assayed for IFN-β at 16 h PI.
This MOI does not result in infection of 100% of cells, thus allowing
ampliﬁcation of the IFN-β response to occur. As shown in Fig. 3,
neither HVP2nv strain induced high levels of IFN-β in any of the three
PMDF cultures. In contrast, HVP2ap strains induced high levels of IFN-
β in both Balb/c and 129 PMDF cultures but not in IFNAR− /− PMDF
cultures. These results suggest that most of the IFN-β response
induced by HVP2ap infection is the result of the ampliﬁcation of IFN-β
expression by uninfected cells in the cultures rather than being due to
expression of high levels of IFN-β by HVP2ap infected cells.
Based on the susceptibility of IFNAR−/− cells to infection by
HVP2ap strains, IFNAR−/− mice should be susceptible to HVP2ap
infection. To test this, mice were infected by skin scariﬁcation with
HVP2ap strain OU2-5 or HVP2nv strain OU1-76. The results of these
experiments are summarized in Table 1. The pathogenesis of HVP2ap
and HVP2nv infections in 129 mice were essentially the same as
described previously for Balb/c mice (Rogers et al., 2006). ID50 and
LD50 values for HVP2nv were not signiﬁcantly different, while the ID50
value for HVP2ap was signiﬁcantly less that of the LD50. The LD50 for
HVP2ap strain OU2-5 in 129 mice (5.14 PFU) was also signiﬁcantly
lower than in Balb/c mice (N6.0 PFU). However, all 129 mice that died
of HVP2ap infection did so at times far past the time at whichmice die
of acute CNS infection (5–6 DPI). At necropsy, all HVP2ap infected 129
mice that died b14 DPI showed signs of dehydration with distended
bladders and impacted intestines. Histological examination of tissues
revealed pathology of the mural ganglia characterized by mild to
moderate inﬁltration of mononuclear cells. Immunohistochemical
staining demonstrated the presence of viral antigen in these ganglia.
These histological ﬁndings are similar to those previously reported in
the large intestines and urinary bladders of HVP2 and Saimirine
herpesvirus 1 infected Balb/c mice (Breshears et al., 2001; Breshears et
al., 2005; Ritchey et al., 2002).
The ID50 and LD50 of HVP2nv were not signiﬁcantly different in
IFNAR− /− and 129 mice (pN0.05), indicating that the lack of the IFN-
β receptor did not result in an increase in the neuropathogenicity of
HVP2nv. In contrast, the LD50 for HVP2ap in IFNAR− /− mice was not
Table 1
Pathogenesis of HVP2 in 129 and IFNAR− /− mice
Mouse
strain
Virus Dose
(PFU)1
Group
size
Clinical
signs
Dead Anti-viral
IgG2
ID503 LD503 Time to
death4
129 HVP2ap 106 5 3 3 5/5 3.50a 5.14b 11.75a
105 5 2 2 5/5
104 5 3 2 3/5
103 5 0 0 0/5
HVP2nv 106 10 10 10 10 3.04a 3.03a 6.5b
105 10 10 10 10
104 5 5 5 5
103 5 2 2 2
102 5 0 0 0
101 5 0 0 0
IFNAR− /− HVP2ap 106 5 5 5 5/5 3.53a 3.07a 5.5b
105 5 5 5 5/5
104 5 5 5 5/5
103 9 3 3 3/9
102 10 1 1 0/95
101 7 0 0 0/7
HVP2nv 104 9 9 9 9/9 2.76 2.82 5.5
103 8 5 5 5/75
102.5 7 2 2 2/7
102 4 0 0 0/4
1) Mice were inoculated by skin scariﬁcation as described (Rogers et al., 2006).
2) Sera frommice survivingN10 DPI were tested by ELISA. Mice that died ≤10 DPI were
considered to be antibody positive for calculation of ID50 values.
3) Values with the same superscript lettering are not statistically different from each
other at p=N0.05.
4) Average time to death (in days) for animals humanely euthanized before termination
of the experiment at 14 DPI. Values with the same superscript lettering are not
statistically different from each other at p=N0.05.
5) No serum was available for testing from one mouse in each of these groups.
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more, HVP2ap infected IFNAR− /− mice died within the same
timeframe as HVP2nv infected mice. As seen for HVP2nv infected
mice, the LD50 and ID50 values for HVP2ap in IFNAR− /−micewere not
signiﬁcantly different from one another (pN0.05). Histologically,
IFNAR− /− mice infected with either HVP2nv or HVPap and 129
mice infected with HVP2nv exhibited lesions having similar quality
and intensity. Cutaneous lesions were characterized by abrupt
epidermal necrosis with multifocal ulceration and the exposed dermis
overlain by a coagulum of ﬁbrin and necrotic cell debris. Scattered
remaining epidermal keratinocytes as well as follicular epithelial cells
exhibited typical herpetic intranuclear inclusion bodies. The dermisTable 2
Comparative pathogenesis of HVP2ap and HVP2nv in 129 and IFNAR− /− mice1
Mouse
strain
Virus Mouse no. 2 DPI 3 DPI
Histopathology Virus isolation Histo
Skin Lumbar
DRG
Skin Lumbar
DRG
Skin
129 HVP2nv 1 1+ 0 4.3e4 0 3+
2 1+ 0 6.2e3 0 4+
3 2+ 0 5.7e4 0 4+
Mean±SEM 3.5±1.5e4 0
HVP2ap 1 1+ 0 2.2e3 0 1+
2 2+ 0 6.2e3 0 3+
3 0 0 1.5e4 0 2+
Mean±SEM 7.8±3.8e3 0
IFNAR− /− HVP2nv 1 3+ 0 6.7e6 0 4+
2 0 0 2.7e6 0 3+
3 1+ 0 1.0e6 0 2+
Mean±SEM 3.5±1.7e6 0
HVP2ap 1 3+ 0 2.1e6 0 4+
2 2+ 0 3.1e6 0 4+
3 2+ 0 1.3e6 0 2+
Mean±SEM 2.2±0.5e6 0
1) Groups of 6micewere infected by skin scariﬁcation. At each time point, 3 micewere used t
mice were used for histopathological examination.
⁎ NS, no sample.contained a moderate to severe, locally extensive inﬂammatory
inﬁltrate composed of neutrophils admixed with fewer macrophages
and lymphocytes. Spinal cords exhibit multifocal to diffuse vacuola-
tion of the neuropil, usually worse on the ipsilateral side, with
numerous scattered (small) neurons predominantly in the ipsilateral
dorsal grey horn exhibiting herpetic inclusion bodies. In lumbar
segments, neurons within dorsal root ganglia and other paraspinal
ganglia were often acutely necrotic or had intranuclear inclusion
bodies. For the most part, although spinal cord lesions were replete
with inclusion bodies, inﬂammation was minimal to non-existent.
Spinal cord and skin sections collected at 14 DPI from 129 mice
infected with HVP2ap exhibited no signiﬁcant microscopic lesions.
In Balb/c mice HVP2ap invades the CNS, but does so much less
effectively than HVP2nv; HVP2ap takes longer to appear in the CNS, is
present in the CNS in lesser amounts, and does not induce as strong an
inﬂammatory response in the CNS (Rogers et al., 2006). However, the
in vivo results above suggest that the kinetics of HVP2ap neuropatho-
genesis in IFNAR−/−mice should be similar to that of HVP2nv. To test
this, groups of six mice were infected and sacriﬁced at 2, 3 and 4 dpi,
three being processed for histopathology and three for virus
quantitation. The results are summarized in Table 2. Differences in
titers of the two viruses in the skin of 129 infected mice were
statistically signiﬁcant (p=N0.05) only at 3 DPI when HVP2ap titers
decrease more than HVP2nv titers. Although HVP2nv titers were
generally higher than HVP2ap titers, the differences at days 2 and 4
were not statistically signiﬁcant due to the small group size and
variation among individual mice. However, comparison of virus titers
in the skin at 2, 3 and 4 DPI revealed that while there was a signiﬁcant
increase in HVP2nv titers each day, there was no statistically
signiﬁcant increase in HVP2ap titers from 2–4 DPI. Based on
histopathological examination, skin lesions were subjectively more
severe in 129 mice inoculated with HVP2nv than HVP2ap, but this
could reﬂect variability in sampling of the inoculation site rather than
deﬁnitive differences in skin lesion severity. Thus, replication in the
skin of 129 mice at the site of inoculation was not dramatically
different for the two HVP2 subtypes up to 4 DPI.
When virus levels in the lumbar spinal cord and associated DRGs of
129 mice were compared, titers of HVP2nv were signiﬁcantly higher
than HVP2ap levels at 3 and 4 DPI (p=N0.05). Microscopic lesions in
the CNS and DRGs were also more severe in HVP2nv infected 129
mice, with larger numbers of necrotic neurons and neurons with
intranuclear inclusion bodies being present than were observed in4 DPI
pathology Virus isolation Histopathology Virus isolation
Lumbar
DRG
Skin Lumbar
DRG
Skin Lumbar
DRG
Skin Lumbar
DRG
2+ 1.9e4 1.0e4 4+ 4+ 2.0e4 4.4e3
0 2.7e4 1.3e3 1+ 2+ 6.5e5 2.0e5
2+ 2.1e4 5.0e3 0 3+ 8.0e4 2.0e5
2.2±0.3e4 5.4±2.5e3 2.5 ± 2.0e5 1.3±0.6e5
0 3.5e2 0 0 2+ 3.8e4 0
0 2.9e3 0 1+ 1+ 5.9e4 5.1e3
1+ 9.0e3 1.4e3 NS⁎ 2+ 4.3e4 6.2e2
4.1±2.6e3 4.7±4.5e2 4.7±0.6e4 1.9±1.6e3
1+ 1.4e6 0 4+ 3+ 1.4e6 9.6e5
1+ 1.1e6 4.9e5 4+ 4+ 5.4e5 6.5e5
0 1.6e5 6.7e3 3+ 1+/− 1.2e6 1.3e6
8.9±3.7e5 1.7±1.6e5 1.0±0.3e6 9.7±1.9e5
2+ 5.8e5 4.3e3 4+ 3+ 2.3e6 1.3e6
0 7.4e5 5.7e3 4+ 2+ 2.4e5 3.4e5
0 1.4e6 1.0e3 4+ 2+ 1.4e6 2.6e5
9.1±2.5e5 3.7±1.4e3 1.3±0.6e6 6.3±3.3e5
o quantitate infectious virus in the skin or lumbar spinal cord and associated DRGs, and 3
284 K.M. Rogers et al. / Virology 386 (2009) 280–289HVP2ap infected mice. In the CNS, the varying severity of microscopic
lesions between HVP2 subtypes was consistent with the observed
difference in virus titers. These results indicate that in 129 mice
HVP2nv is better able to invade and/or replicate in the CNS than the
HVP2ap.
Results were very different in IFNAR− /− mice. In the skin at the
site of inoculation there was not a statistically signiﬁcant increase in
viral titers of either virus between 2 and 4 DPI, nor were titers of
HVP2nv signiﬁcantly different from those of HVP2ap at any time
point. While levels of HVP2ap and HVP2nv in the skinwere equivalent
in IFNAR−/−mice, there was a signiﬁcant difference in the amount of
each virus present in the skin of 129 vs. IFNAR− /− mice at all time
points. The same was true for virus levels in the CNS of IFNAR− /−
mice: while titers of both HVP2ap and HVP2nv increased dramatically
between 2 and 4 DPI, titers of the two virus subtypes were not
signiﬁcantly different from each other. At each time point, microscopic
skin lesions in the skin and CNS were of similar character and severity
between the two virus subtypes. The lack of variation in lesion
severity in IFNAR− /− mice is consistent with the lack of difference
between tissue virus titers in IFNAR− /− mice. Thus, consistent with
the equivalent LD50 values for the two HVP2 subtypes in IFNAR− /−
mice (Table 1), there was no apparent difference in the ability of
HVP2ap and HVP2nv to replicate in the skin at the site of inoculation
or to invade the CNS in IFNAR−/− mice.Fig. 4. Location of variable amino acid residues in the HVP2 UL41 (vhs) polypeptide. AA seq
were aligned to identify residues that varied among isolates. The sequences for HSV1 and H
lack of shading. Residues that vary between HSV and HVP2 are indicated by gray/black sh
triangle below the sequences and the two isolate-speciﬁc substitutions are indicated by anComparison of virus levels in tissues of 129 vs. IFNAR− /− mice
revealed that the in the skin, titers of both viruses were signiﬁcantly
higher at all time points in IFNAR−/−mice (p=N0.05).When titers of
virus in the CNS were compared, titers of HVP2nv at 3 and 4 DPI were
not signiﬁcantly different in the two mouse strains. However, CNS
titers of HVP2apwere signiﬁcantly higher (p=N0.05) in IFNAR− /− as
compared to 129 mice at 3 and 4 DPI. Thus, the ability of HVP2ap to
replicate locally in the skin to levels equivalent to that of HVP2nv
appears to correlate with the ability of the virus to effectively invade
the CNS.
In HSV, the vhs protein encoded by the UL41 gene has been shown
to be important in abrogating the IFN-β response of cells following
infection, presumably through the ability of the vhs protein to degrade
some cellular mRNAs (Kwong and Frenkel, 1987, 1989; Murphy et al.,
2003). The reduced pathogenicity of HSV UL41 deletion mutants in
mice (Smith et al., 2000, 2001; Strelow et al., 1997; Strelow and Leib,
1995; Suzutani et al., 2000) is similar to that of HVP2ap strains, raising
the possibility that differences in the UL41 gene might underlie the
dichotomous neuropathogenicity of the two HVP2 subtypes. To
address this possibility the UL41 ORF of four HVP2 strains (2
apathogenic and 2 neurovirulent) was sequenced and the predicted
amino acid sequences aligned to identify substitutions that correlated
with the neurovirulence phenotype of the isolates (Fig. 4). Therewere
six amino acid residues that showed variation. Although two of theuences of four HVP2 strains (HVP2ap A951 and OU2-5 and HVP2nv OU1-76 and X313)
SV2 are included for reference. AA residues conserved in all sequences are indicated by
ading. The four potential HVP2 subtype-speciﬁc substitutions are indicated by a solid
open triangle below them.
Fig. 5. Characterization of UL41 mutants. One-step growth curves performed in Vero
cells are shown in A. Viruses included the parental HVP2nv (■——■), HVP2nv Δ41
(▲………▲), HVP2nv Δ41C (□−−−−□) and HVP2nv Δ41R (●——-●). Northern blot of
β-actin mRNA in infected cells is shown in B. Total RNAwas isolated from cells at 4 h PI,
15 μg loaded in each lane, and northern blotting performed using the Vero cell β-actin
gene as probe. IFN-β production in PMDF cultures is shown in C. Cultures were infected
with the indicated viruses at an MOI=1 PFU/cell and the medium assayed for IFN-β at
24 h PI. IFN-β levels that were signiﬁcantly different (p=N0.05) from the level induced
by the parental HVP2nv virus are indicated by an asterisk above the standard error bar.
Table 3
Pathogenesis of HVP2 UL41 mutants in Balb/c mice
Dose (PFU) OU1-76 OU2-5 Δ41 Δ41C Δ41R
106 ND2 1/101 ND ND ND
105 8/8 0/8 10/10 10/10 5/5
104 6/8 0/8 8/12 9/12 10/12
103 2/12 ND 1/11 1/12 3/12
102 0/8 ND 0/5 0/5 0/5
LD503 103.6 N106 103.9 103.7 103.4
1) Number of mice that developed clinical signs of fatal CNS infection in each group.
2) ND, not done.
3) The LD50 for HVP2ap OU2-5 was signiﬁcantly different (p=N0.05) from the LD50 of
all other viruses (which were not signiﬁcantly different from each other).
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the neurovirulence phenotype. None of these four substitution sites
were located in a highly conserved region of the vhs polypeptide. Two
were conservative substitutions (Ile↔Leu and Ala↔Thr) and two
were non-conservative substitutions (both Leu↔Pro). The two
Leu↔Pro substitutions were located very near each other. Since
proline residues induce turns in the polypeptides, it is possible that the
Leu/Pro substitutions ‘offset’ any effect via their close proximity in the
peptide. Thus, there did not appear to be any major difference in the
vhs sequences of HVP2ap and HVP2nv isolates.
To experimentally assess the role of the UL41 gene in pathogenicity
of HVP2 isolates, the UL41 ORF was deleted from a neurovirulent
strain of HVP2 (designated Δ41) and then replaced with the UL41 ORF
from either an apathogenic virus (Δ41C, a recombinant) or the parent
neurovirulent virus (Δ41R, a revertant). Based on one-step growth
curves, there were no differences in the ability of any of these viruses
to replicate in Vero cells (Fig. 5A). While degradation of host cell β-
actin mRNA occurred in cells infected with any of the viruses
containing an intact UL41 ORF (wt, Δ41C and Δ41R), β-actin mRNA
degradation was more efﬁcient in cells infected with the HVP2ap
parental virus than in cells infected with HVP2nv parent virus, and β-
actin mRNA degradation by the Δ41C recombinant and the Δ41Rrevertant reﬂected that of the parent virus their UL41 ORFs were
derived from (Fig. 5B). The recombinant Δ41C replicated in PMDF
cultures as efﬁciently as the HVP2nv parent and Δ41R revertant
viruses, destroying the entiremonolayer within 48 h. In contrast, virus
lacking the UL41 ORF (Δ41) did not exhibit signiﬁcant degradation of
β-actinmRNA and grewmuch slower in PMDFs than the other viruses.
However, unlike HVP2ap plaques which ceased to expand after 24 h
andwere eventually overgrown by uninfected cells (Rogers, Black, and
Eberle, 2007), HVP2nvΔ41 plaques continued to slowly enlarge in size
up to 6 days PI when the experiment was terminated.
The ability of the UL41 mutants to prevent an IFN-β response was
compared by assaying the medium from infected PMDF cultures at
24 h PI (Fig. 5C). Cultures infectedwith the Δ41mutant produced high
levels of IFN-β typical of HVP2ap strains. Cultures infected with the
recombinant Δ41C produced low levels of IFN-β comparable to those
produced by wt HVP2nv and Δ41R revertant infected cultures. These
results indicate that while the vhs protein is not responsible for the
difference in the ability of HVP2ap and HVP2nv strains to prevent an
IFN-β response by the host cell, its absence does allow the host cell to
mount an effective IFN-β response following infection.
Since the Δ41C recombinant virus grows as well as the parental
HVP2nv virus in PMDF cultures and as virus replication in PMDF
cultures correlates with the neurovirulence of HVP2 isolates (Rogers,
Black, and Eberle, 2007), the Δ41C recombinant should have a
neurovirulence phenotype similar to the parental HVP2nv and Δ41R
revertant viruses. To test this, Balb/c mice were infected with each
virus by skin scariﬁcation. The results are summarized in Table 3. As
expected, the LD50 of the revertant virus (Δ41R) was not signiﬁcantly
different from that of the parental HVP2nv virus. Most mice rapidly
developed paresis of the ipsilateral hind foot by 5–6 days PI, followed
by paralysis and euthanasia within 24 h. Mice infected with the same
dose of the Δ41C recombinant virus followed a similar pathogenic
progression of infection and time course of disease. Differences in the
LD50 and mean time to death of the wt HVP2nv, Δ41C recombinant
and Δ41R revertant viruses were not statistically signiﬁcant but were
different from that of HVP2ap. Mice inoculated with the Δ41 deletion
mutant exhibited a somewhat delayed development of paresis of the
ipsilateral hind foot, and paresis did not always progress to full
paralysis of the affected limb. As time progressed, skin lesions at the
site of inoculation in Δ41 infected mice continued to develop and
spread. Despite the prolonged disease progression, the LD50 of theΔ41
deletion mutant was not signiﬁcantly different from that of the other
HVP2nv viruses but was signiﬁcantly lower than that of HVP2ap
(p=N0.05). Thus, while deletion of the UL41 ORF did qualitatively
affect the neuropathogenicity of HVP2nv, it did not severely reduce
neuropathogenicity of the virus as has been reported for HSV1 and
HSV2 (Korom, Wylie, and Morrison, 2008; Strand and Leib, 2004;
Strelow and Leib, 1995).
Histologically, skin and spinal cord lesions in mice infected with
the UL41 mutants were qualitatively and quantitatively similar to
those previously described in Balb/c mice infected with wt HVP2nv
isolates. Brieﬂy, there was epithelial necrosis and ulceration with
Fig. 6. Comparison of spinal cord lesions in mice infectedwith UL41mutants. Lumbar spinal cord lesions in Balb/c mice infectedwith the deletion mutant Δ41, the recombinantΔ41C
or the Δ41R revertant exhibit roughly the same quantity and quality of histological lesions characterized by multifocal to disseminated white matter vacuolation, mild inﬂammation
primarily in the dorsal grey horn and funiculus, and numerous herpetic inclusion bodies (not visible at this magniﬁcation). H and E stain; bar=260 μm.
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well as in scattered remnant epidermal cells and follicular epithelial
cells. The dermis exhibited moderate to severe disseminated mono-
nuclear and neutrophilic dermatitis. Immunostaining revealed con-
spicuous HVP2 antigen conﬁned to the epithelium. In the lumbar
spinal cord, there was multifocal to disseminated vacuolation of the
ipsilateral white matter in all funiculi, most usually severe in the
dorsal and lateral funiculus (Fig. 6). Therewas also mild, mononuclear
inﬂammation in the ipsilateral dorsal grey horn and funiculus with
numerous conspicuous herpetic inclusions within small neurons and
glial cells. The only quantitative difference among the mutants was
that extension of the inﬂammation to the brain only occurred in wt
HVP2nv, Δ41C and Δ41R; there were no brain lesions observed in 33
brains examined from Δ41 infected mice, even in those inoculated
with high doses of virus.
Discussion
In their natural host, acute infection by HSV and related primate
herpesviruses is normally followed by the establishment of a latent
infection within the PNS that persists for the life of the host. In
contrast to the usually mild, self-limiting infections that occur in the
natural host, when these viruses infect a non-natural host they can
produce severe, frequently fatal infections that involve the CNS such
as occurs when BV infects humans. The host and viral mechanisms
that allow these viruses to enter and spread via lytic infection within
the CNS in a non-natural host rather than establishing a latent
infection in the PNS as occurs in the natural host are largely unknown.
A more thorough understanding of virus/host interactions which
determine the serious outcome of cross-species or zoonotic infections
is critical.
With regard to pathogenicity, the HVP2nv-mouse model closely
resembles human BV infections. Although HVP2nv is not neuroviru-
lent in its natural baboon host and only rarely causes severe infections
in baboons (Rogers et al., 2005), HVP2nv isolates are extremely
neuropathogenic in mice. In contrast, mice are able to very efﬁciently
control infections by naturally occurring HVP2ap isolates. Previous
studies indicate that control of HVP2ap infections in mice begins
locally at the site of inoculation and continues even within the CNS
(Rogers et al., 2006). Since the pathogenesis of HVP2nv and HVP2ap
infection in mice diverges well before an adaptive immune response
develops, innate immunity likely plays a major role in effecting the
divergent pathogenicity of the two HVP2 subtypes. IFN-β appears to
be involved in controlling HVP2ap infections since HVP2nv isolates do
not induce and/or overcome an IFN-β response, and are thus not as
susceptible to IFN-β in vitro as HVP2ap isolates are (Rogers et al.,
2007). The experiments presented here extend these observationsand conﬁrm a critical role for the type I IFN response in controlling
HVP2ap infections in vivo.
Other investigators have observed that HSV1 and HSV2 UL41
mutants exhibit reduced neurovirulence in the mouse model, but in
IFNAR− /− mice their neurovirulence is comparable to that of the
wild-type virus (Leib et al., 1999;Murphy et al., 2003). Consistent with
these HSV studies, HVP2ap isolates are just as neuropathogenic as
HVP2nv isolates in IFNAR− /− mice as evidenced by similar LD50
values and similar levels of virus in the skin at early times PI. The
relationship between the ID50 and LD50 for HVP2ap isolates in IFNAR
− /−mice also reﬂects that of HVP2nv isolates in 129 and Balb/c mice:
the ID50 and LD50 values are not signiﬁcantly different, indicating that
whenHVP2ap establishes an infection in IFNAR− /−mice it inexorably
progresses to death of the host. Similarly, temporal progression of
virus from the peripheral site of inoculation into the CNS is similar for
both HVP2 subtypes in IFNAR−/−mice. Since the level of virus in the
lumbar spinal cord and associated DRGs represents the earliest point
in the pathogenic process that is demonstrably different for HVP2ap
and HVP2nv in wild-type 129 mice, it is likely that the ability of the
host to delay and/or lessen entry of virus into the CNS plays a critical
role in the dichotomous outcome of infection with the two HVP2
subtypes. In contrast, studies with HSV have shown that replication of
the virus at the inoculation site appears to be important in that this
replication ampliﬁes the amount of virus thereby increasing the
likelihood of viral entry into unmyelinated nerve ﬁbers present in the
skin to provide access to the CNS (Cunningham et al., 2006; Mossman
and Ashkar, 2005; Yamada et al., 1986). While differences in the
amount of HVP2ap vs. HVP2nv in skin were statistically signiﬁcant
only at 3 DPI, levels of HVP2ap were lower than those of HVP2nv at 2
and 4 DPI. Given the small group size used (3 mice/group), it is
possible that that were larger group sizes used these differences may
have been signiﬁcant. If so, our results would be consistent with the
results of other investigators studying HSV pathogenesis which
suggest that reduction of virus replication at the site of inoculation
is critical in determining the outcome of the infection.
Another observation from these experiments was that the inability
of the host to mount a type I IFN response did not have a major effect
on the temporal or spatial progression of HVP2nv infection at early
times PI. The only noticeable difference was that in IFNAR−/− mice
higher titers of HVP2nvwere present in skin at the inoculation site at 2
DPI than in 129 mice. However, HVP2ap titers at 2 DPI at the site of
inoculation were also higher in the knock-out mice vs. wild-type
indicating that higher viral titers at this time is a function of themouse
genotype rather than being peculiar to HVP2nv. This suggests that an
intact type I IFN response does not interferewith the ability of HVP2nv
to invade and replicate within the CNS. The higher titers of HVP2nv in
skin of IFNAR−/−mice at 2 DPI suggests that the early IFN response at
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HVP2nv replication in the skin at very early times after infection. This
would again be consistent with the hypothesis that controlling the
initial replication and ampliﬁcation of virus at the site of inoculation is
a critical factor in the ability of the host to prevent virus from gaining
access to the CNS.
In previous experiments pre-treatment of PMDF cultures with
recombinant murine IFN-β did not effectively protect cells from
HVP2nv infection, suggesting that it may be the induction of the IFN
system rather than the production of type I IFNs which is important
for controlling HVP2 infections (Rogers et al., 2007). In addition, while
we have not detected IFN-α induction by HVP2 in vitro, IFNAR loss
would affect both IFN-β and IFN-α induced pathways of antiviral
immunity. As such, the importance of IFN-α in controlling HVP2
infection in vivo can not be ruled out. While type I IFNs are important
for the early, innate response to viral infection they also contribute to
the antiviral immune response by stimulating the cytotoxic activity of
natural killer cells, signaling for dendritic cell maturation, and
promoting various T-cell functions, including expansion of the
memory population (Garcia-Sastre and Biron, 2006). Further studies
are needed to determine the exact IFN mechanism that so efﬁciently
controls HVP2ap while allowing CNS invasion by HVP2nv.
In HSV1 and HSV2 the UL41 gene encoding the vhs protein has
been shown to play a major role in determining the neurovirulence of
the virus. UL41mutants of HSV replicate normally in tissue culture but
are impaired in their ability to invade the CNS from peripheral sites
and are defective in their ability to spread within the CNS of mice
(Korom et al., 2008; Smith et al., 2000, 2001; Strelow et al., 1997;
Strelow and Leib, 1995). This is very similar to what is observed for
apathogenic isolates of HVP2. However, replacement of the HVP2nv
UL41 ORF with an HVP2ap UL41 ORF did not affect the ability of the
virus to infect mice and invade the CNS, nor did it result in high levels
of IFN-β production in infected PMDF cultures. This demonstrates that
the UL41 protein alone is not responsible for the disparate neuroviru-
lence of the two HVP2 subtypes.
Although the UL41 gene does not appear to underlie the
neuropathogenic differences of HVP2ap and HVP2nv isolates, it does
appear to play a role in allowing HVP2 to prevent the host IFN-β
response. Deletion of the HVP2nv UL41 gene resulted in a strong IFN-β
response in infected PMDF cultures. Consistent with this, HVP2nvΔ41
replicated poorly in PMDFs while HVP2ap abortively infects PMDFs.
HVP2nvΔ41 also displayed reduced pathogenesis in mice much as
described for HSV UL41 deletion mutants. While HVP2nvΔ41 can
invade the CNS, it does not produce the rapid and severe CNS disease
observed in mice infected with wt HVP2nv. Since HVP2nvΔ41 infected
PMDF cultures produce high levels of IFN-β comparable to those
induced by HVP2ap isolates, the UL41 gene does appear to be involved
in preventing or suppressing the IFN-β response. The recombinant
HVP2nvΔ41C carrying an HVP2ap UL41 gene behaved similar to the
wt HVP2nv in all respects, including suppression of the host IFN-β
response. This demonstrates that the vhs protein itself is not
functionally different in apathogenic and neurovirulent HVP2 isolates.
This apparent inconsistency could be explained by the interaction of
the vhs protein with some other viral factor(s) to suppress the IFN-β
response, this second factor being the one actually responsible for the
disparate pathogenic phenotype of HVP2 isolates.
The interplay between large, complex herpesviruses and the
intricate workings of the host immune system is understandably
convoluted. In addition to vhs,α-herpesviruses encodenumerous other
IFN antagonists which most likely interact with multiple IFN induction
pathways in the host. To further complicate matters, during HSV
infection pathogen recognition and subsequent type I IFN production
has been shown to be both cell-type and time-dependent (Rasmussen
et al., 2007).While pDCs are responsible via Toll-like receptor 9 for early
productionof IFN in response toHSV infection invivo,macrophages and
ﬁbroblasts also produce type I IFNs later in infection. The production oftype I IFNs in these cell types is dependent on both viral entry and
replication, and is ablated in cells unable to signal through the
mitochondrial antiviral signaling (MAVS) protein pathway. Therefore,
interference with both the MAVS- and TLR9-dependent pathways at
multiple times PI may be necessary for HVP2nv to ensure sufﬁcient
replication in the dermatome for entry into the CNS.
The fact that the LD50 for HVP2ap isolates in IFNAR− /− mice was
the same as the LD50 for HVP2nv strains suggests that the type I IFN
response may be the primary if not sole facet of the host innate
response involved in the initial control of HVP2ap infection. The basis
for the divergent neuropathogenicity of HVP2nv vs. HVP2ap isolates in
mice thus appears to lie in the ability of the HVP2nv isolates to prevent
and/or overcome the host type I IFN response and/or downstream
host effector mechanisms which are controlled and initiated via the
type I IFN pathway. The UL41-encoded vhs protein gene does appear
to be directly involved in preventing the IFN-β response in that
deletion of the UL41 gene from HVP2nv results in IFN-β production
following infection. However, since the HVP2nvΔ41 deletion mutant
can replicate in PMDF cells and mice despite the induction of an IFN-β
response, the vhs protein does not appear to be the primary factor
responsible for the ability of HVP2nv to overcome the IFN-β response.
It remains to be seen how HVP2nv isolates accomplish this and why
HVP2ap isolates are unable to do so.
Methods and materials
Animals
129 mice (female and male) weighing 10–12 g were obtained
from The Jackson Laboratory (Bar Harbor, ME). Two breeding pairs of
IFNAR− /− mice were generously provided by Dr. H.W. Virgin
(Washington University School of Medicine, St. Louis, MO) and
were bred and raised at Oklahoma State University. The genotype and
genetic background of these IFN-β receptor knock-out mice has been
described (Muller et al., 1994). Mice were weaned and used for
experiments at a weight of 10–12 g (21–25 days of age). Balb/c mice
were purchased from Charles River Labs.
Viruses and cell cultures
The origins and neuropathogenicity of the HVP2ap (A951 and
OU2-5) and HVP2nv (OU1-76 and X313) strains used in this study
have been described in detail elsewhere (Eberle et al., 1995, 1997a,
1998; Rogers et al., 2003). All virus stocks were grown and titrated in
Vero cells. PMDF cultures from Balb/c, 129 and IFNAR−/− mice were
prepared and cultured as described previously (Rogers et al., 2007).
Vero cells were originally obtained from the American Type Culture
Collection (Rockville, MD, USA).
PMDF cultures in multi-well trays were mock infected with an
uninfected Vero cell lysate or with virus as described (Rogers et al.,
2007). After 1 h at 39 °C, the inoculumwas removed, cells werewashed
withwarmPBS, and freshmedia containing2%FBS added. Cultureswere
photographed using a Nikon Eclipse TE-200 inverted ﬂuorescent
microscope (Melville, NY)with attachedRS Photometrics digital camera
prior to harvesting the cells for quantitation of infectious virus by
standard plaque assay on Vero cells (Rogers et al., 2003). A commercial
ELISA kit (LKT Laboratories; St. Paul, MN) was used to quantitate IFN-β
levels in the extracellularmedia of infected cell cultures. All assayswere
performedonduplicate samples andwere repeatedat least twice. Levels
of anti-HVP2 IgG in mouse serum were determined by ELISA as
described (Ohsawa et al., 1999; Rogers et al., 2003).
Construction of recombinant viruses
Approximately 2 Kbp of sequences ﬂanking each side of the UL41
ORF of HVP2nv strain OU1-76 were ampliﬁed by PCR and a GFP
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place of the UL41 ORF via restriction sites incorporated at the UL41
start and stop codons (Sph1 and Xba1, resp.). This construct was
excised from the vector and transfected into Vero cells using the
GenePorter reagent as recommended by themanufacturer (Genlantis;
San Diego, CA). At 24 h post transfection, the cell culture was infected
with HVP2nv (OU1-76) at an MOI=1 PFU/cell, incubated at 37 °C
until CPE was complete to allow homologous recombination to occur
between the construct and viral DNA, and the cultures harvested as a
viral stock. Virus was then plated on Vero cells and observed at 48 h PI
under an inverted ﬂuorescent microscope (Black et al., 2002). GFP-
positive plaques were picked and plaque puriﬁed four times. Deletion
of the UL41 ORF and proper insertion of the GFP expression cassette in
place of the UL41 ORF was conﬁrmed by Southern blot analysis and
PCR/sequencing (Eberle et al., 1997b). This UL41 gene deletion virus
was designated HVP2 OU1-76Δ41.
Construction of a revertant (HVP2 OU1-76Δ41R) and a recombi-
nant virus (HVP2 OU1-76Δ41C) followed the same basic procedure.
Brieﬂy, the UL41 ORF was ampliﬁed by PCR from the parental HVP2nv
strain OU1-76 (to construct the revertant virus) or fromHVP2ap strain
OU2-5 (to construct the recombinant) and inserted into the ﬂanking
sequences used to construct the UL41 gene deletion virus using the
same restriction sites. After transfection of the constructs into Vero
cells, the cultures were infected with the GFP-positive HVP2 OU1-
76Δ41 virus, GFP-negative plaques picked 48 h later, and the virus
plaque puriﬁed. Conﬁrmation of restoration of the UL41 ORF, its
sequence integrity across the entire ORF, and deletion of the GFP
expression cassette were conﬁrmed by Southern blot analysis and
PCR/sequencing.
Mouse inoculations
Mice were infected by scariﬁcation on the hind ﬂank as described
previously (Rogers et al., 2006). Brieﬂy, mice were shaved, an area of
skin approximately 7×7 mm was lightly scariﬁed by 5×5 scratches
with a 22 gauge needle in a checkerboard pattern, and 10 μl of virus
applied to the area and ‘rubbed in’ with a pipet tip. Sterile PBS was
used as diluent for inoculum dilutions. Once infected, mice were
observed twice daily for clinical signs of infection. All mice were
humanely euthanized by isoﬂuorane overdose when clinical signs of
infection became severe or at termination of the experiment at
14 days post infection (DPI). Blood was collected by cardiac puncture
at the time of death/euthanasia and the serum stored at –80 °C.
Pathology and virus isolation
Following euthanasia, mice were opened with a midline abdom-
inal incision and placed in buffered formalin for 24–48 h before tissues
were collected for pathological examination. All histological proce-
dures were conducted as previously described (Ritchey et al., 2002;
Ritchey et al., 2005; Rogers et al., 2006). For virus isolation, tissues
were sterilely dissected, placed in a sterile microfuge tube, weighed,
and frozen at −80 °C. For assay of infectious virus, sterile PBS was
added to tissue samples, tissues were homogenized using a motorized
pestle, insoluble debris removed by centrifugation at 14,000×g for
2 min, and the clariﬁed supernatant transferred to a clean tube.
Infectious virus was quantitated by plaque assay on Vero cells and
expressed as PFU/g of tissue.
Statistical analyses
The 50% infectious dose (ID50) and the 50% lethal dose (LD50) were
calculated by probit regression with PROC PROBIT in PC SAS Version
9.1 (SAS Institute, Cary, NC, USA). The values calculated were
compared by methods developed for effective dosages (Ritchey et
al., 2005; Rogers et al., 2006). The ID50 was deﬁned by the presence ofanti-HVP2 IgG in serum of mice that survived to at least 11 DPI. Mice
that died prior to 11 DPI were assumed to be infected and were
considered to be positive for calculation of ID50 values. LD50 values
were based on animals that either died as a result of the infection or
required euthanasia due to the severity of disease. Virus titers in
tissues were analyzed to compare levels of HVP2nv vs. HVP2ap in
differentmouse strains and at different times PI by analysis of variance
procedures with PROC MIXED in PC SAS Version 9.1 (SAS Institute,
Cary, NC). Virus titer values were transformed using a log base 10
function prior to analysis. Signiﬁcant differences in the simple effects
of one factor given values of the other factors were determined by
protected pair-wise t tests with a SLICE option in an LSMEANS
statement.
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